- Home
- Companies
- micronesia
- disease progression
Show results for
Refine by
Disease Progression Suppliers Serving Micronesia
88 companies found
based inSanta Clara, CALIFORNIA (USA)
Ancora Heart is dedicated to providing new treatment options for patients suffering from heart failure. Our team has a deep appreciation for the challenges faced by the estimated 26 million patients across the globe who are living with this chronic, ...
Heart failure, sometimes called congestive heart failure or CHF, is a condition in which your heart slowly weakens and loses its ability to pump enough oxygen-rich blood to the body. It is a chronic, progressive ...
based inTewksbury, MASSACHUSETTS (USA)
Cambridge Isotope Laboratories, Inc. (CIL) is the world’s leading producer of stable isotopes and stable isotope-labeled compounds. With over 400 employees and laboratories in four countries, CIL specializes in the process of labeling biochemical ...
based inWayne, PENNSYLVANIA (USA)
Sino Biological is committed to providing high-quality recombinant protein and antibody reagents and to being a one-stop technical services shop for life science researchers around the world. All of our products are independently developed and ...
based inEmeryville, CALIFORNIA (USA)
Injectsense enables tracking of progressive disease indicators and improved therapy management by providing continuous, clinically actionable information through an injectable ultra-miniature sensor coupled with a secure digital health platform. Our ...
based inOakland, CALIFORNIA (USA)
Eko is your all-in-one screening and telemedicine solution, helping you detect cardiac conditions easier and provide timely care from anywhere. The ability to listen is the ability to care. Eko understands how important listening can be for ...
DUO is the first cardiac assessment tool that functions as an ECG and digital stethoscope, used to detect early signs of heart disease and facilitate more personalized care in any environment. DUO can be used with or without included ...
based inCambridge, MASSACHUSETTS (USA)
The exponential growth of biomedical data, driven by the adoption of electronic medical records (EMRs), provides an unprecedented opportunity to create transformative technologies and products in healthcare. nference partners with medical centers to ...
Our scientists use the nference platform and data in collaboration with your teams to tackle your most important questions and challenges. nference is creating the largest labeled EMR dataset in healthcare. EMR data contains longitudinal real-world, ...
based inGuildford, UNITED KINGDOM
Datar Cancer Genetics is a leader in developing blood-based diagnostics that can detect cancer early, offer non-invasive investigations for better treatment options, and track the progression of the disease or its recurrence. We believe that ...
Cancertrack is an advanced non-invasive blood test which provides real time intel on the status of a malignancy from a safe, simple and quick blood draw. Cancertrack profiles molecular features in circulating tumor DNA and circulating tumor RNA and ...
based inOxford, UNITED KINGDOM
Evox Therapeutics is a privately held, Oxford-based biotechnology company focused on improving the natural delivery capabilities of exosomes, and developing an entirely new class of therapeutics. Backed by leading venture capital groups and ...
based inImmeuble l’Etendard, FRANCE
Carmat will provide cardiologists with innovative technologies that save lives and improve the quality of life for patients with advanced heart failure. Become the primary alternative to heart transplants with the implementation of our Total ...
based inGuangzhou, CHINA
Guangzhou Wondfo Biotech Co., Ltd., headquartered in Guangzhou science city, has been focusing on the R&D, production, sales and service of point-of-care testing (POCT) products and providing customers with professional rapid diagnosis and chronic ...
RBD (receptor binding domain) of 2019-nCoV virus S1 protein is the region that binds to the ACE2 receptor on human cells as the first step of virus invading. The majority and most potency neutralizing antibody targets the epitopes on RBD, therefore ...
based inWest Lafayette, INDIANA (USA)
Tymora Analytical Operations provides diagnostic development and exosome proteomics contract services and products for improved cancer research. Tymora’s primary goal is to enable the shift from tissue to liquid biopsy. Our new technologies allow ...
based inCarlton South, AUSTRALIA
Chimeric Therapeutics is a clinical stage cell therapy company focused on bringing the promise of cell therapy to life for more patients with cancer. We believe that cellular therapies have the promise to cure cancer not just delay disease ...
based inCottesloe, AUSTRALIA
Neuroscientific Biopharmaceuticals is an Australian public company (ASX:NSB) developing novel peptide-based pharmaceutical products that target a number of neurological disorders and diseases of the eye that have high unmet medical need. Our vision ...
Multiple indications with unmet medical need. “Our company goal is to create new products that reach their target in the brain and act as a protector against nerve cells injury. Currently, there are no approved drugs that can slow down or halt ...
based inMiddletown, PENNSYLVANIA (USA)
MacuLogix is a company that equips eye care professionals with the technology, tools, and education needed to help identify and manage age-related macular degeneration (AMD) patients early, before irreversible vision loss has occurred. We can help ...
Active monitoring of AMD can allow patients to enjoy additional years of good central vision, enhancing the odds of a better quality of life. Diagnosing the disease as early as possible offers time to take measures that may slow ...
based inRedwood City, CALIFORNIA (USA)
A global leader in interventional pulmonology, planning tools, and treatments for obstructive lung disease. Based in Redwood City, California, and Neuchâtel, Switzerland, Pulmonx is the maker of the Zephyr Endobronchial Valve. The Zephyr® Valve was ...
based inOxford, UNITED KINGDOM
As a leading global provider of diagnostic genomic solutions, our goal is to enable researchers and clinical decision makers to reach the right decisions for each patient, every time. The quality and innovation built into our products for NGS, ...
The P53 probe mix consists of a 161kb probe, labelled in red that covers the whole P53 (TP53) gene and the flanking regions. The probe mix also contains a control probe for the 17 centromere (D17Z1) that is labelled in ...
based inNew York, NEW YORK (USA)
Oramed Pharmaceuticals (NASDAQ: ORMP) has developed an innovative technology to transform injectable treatments into oral therapies. Oramed’s flagship product, an oral insulin capsule, has the potential to better the lives of millions of diabetics ...
Diabetes is a chronic condition characterized by hyperglycemia, or elevated blood glucose levels. If left untreated, diabetes may lead to complications such as cardiovascular disease, chronic renal failure, retinopathy and ...
based inSan Jose, CALIFORNIA (USA)
LimFlow was founded with the deep belief that more could be done for the millions of patients worldwide suffering from the most severe form of peripheral artery disease — Chronic Limb-Threatening Ischemia (CLTI) — and who are facing the prospect of ...
Living with Peripheral Artery Disease (PAD) that progresses to CLTI is challenging. Life revolves around chronic leg pain that can become unbearable over time. The end stage of the disease is ...
based inAmsterdam, NETHERLANDS
Self-screen has a long history and track record in translational HPV related science. The company was founded in 2008 to advance the implementation of scientific discoveries in the field of HPV related cancer screening into routine practice. Our ...
based inBox Hill North, AUSTRALIA
Magellan is a private Australian company with expertise in research, development and manufacturing of stem cells for the treatment of osteoarthritis. We lead the way globally in scientific, clinical and commercial expertise for stem cell supply and ...